UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Comment on Sundin et al.: ENETS Consensus Guidelines

Neuroendocrinology, 2019-06, Vol.108 (4), p.365-365

2019

Volltextzugriff (PDF)

Positron Emission Tomography/Computed Tomography and Whole-Body Magnetic Resonance Imaging in Staging of Advanced Nonsmall Cell Lung Cancer—Initial Results

Investigative radiology, 2008-05, Vol.43 (5), p.290-297

2008

Volltextzugriff (PDF)

Long-term benefit of intracardiac delivery of autologous granulocyte–colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct

Cytotherapy (Oxford, England), 2009, Vol.11 (8), p.1002-1015

2009

Volltextzugriff (PDF)

Factors Influencing [F‐18] 2‐Fluoro‐2‐Deoxy‐d‐Glucose (F‐18 FDG) Uptake in Melanoma Cells: The Role of Proliferation Rate, Viability, Glucose Transporter Expression and Hexokinase Activity

Journal of dermatology, 2005-05, Vol.32 (5), p.316-334

2005

Volltextzugriff (PDF)

FDG-PET imaging for the staging and follow-up of small cell lung cancer

European Journal of Nuclear Medicine, 2001-04, Vol.28 (4), p.483-488

2001

Volltextzugriff (PDF)

Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome

European journal of nuclear medicine and molecular imaging, 2002-09, Vol.29 (9), p.1118-1124

2002

Volltextzugriff (PDF)

Factors Influencing [F‐18] 2‐Fluoro‐2‐Deoxy‐d‐Glucose (F‐18 FDG) Accumulation in Melanoma Cells: Is FDG a Substrate of Multidrug Resistance (MDR)?

Journal of dermatology, 2005-05, Vol.32 (5), p.335-345

2005

Volltextzugriff (PDF)

First clinical evidence that imaging with somatostatin receptor antagonists is feasible

Journal of Nuclear Medicine, 2011-09, Vol.52 (9), p.1412-1417

2011

Volltextzugriff (PDF)

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method

The Journal of nuclear medicine (1978), 2021-01, Vol.62 (1), p.37-42

2021

Volltextzugriff (PDF)

Residual thymic tissue and lymph node involvement by acute myeloid leukaemia presenting as mediastinal, strongly 18 FDG-PET-positive masses

European journal of haematology, 2017-09, Vol.99 (3), p.286-288

2017

Volltextzugriff (PDF)

Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis

European journal of nuclear medicine, 2002-02, Vol.29 (2), p.237-242

2002

Volltextzugriff (PDF)

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV max Method

Journal of Nuclear Medicine, 2021-01, Vol.62 (1), p.37-42

2021

Volltextzugriff (PDF)

Residual thymic tissue and lymph node involvement by acute myeloid leukaemia presenting as mediastinal, strongly 18FDG‐PET‐positive masses

European journal of haematology, 2017-09, Vol.99 (3), p.286-288

2017

Volltextzugriff (PDF)

Thymic Carcinoma with Overexpression of Mutated KIT and the Response to Imatinib

The New England journal of medicine, 2004-06, Vol.350 (25), p.2625-2626

2004

Volltextzugriff (PDF)

Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene

JAMA : the journal of the American Medical Association, 2005-10, Vol.294 (16), p.2057

2005

Volltextzugriff (PDF)

Fluorine-18 DOPA PET Imaging of Paraganglioma Syndrome

Clinical nuclear medicine, 2006-01, Vol.31 (1), p.39-41

2006

Volltextzugriff (PDF)

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Annals of hematology, 2019-04, Vol.98 (4), p.897-907

2019

Volltextzugriff (PDF)

Positron Emission Tomography-Measured Abnormal Responses of Myocardial Blood Flow to Sympathetic Stimulation Are Associated With the Risk of Developing Cardiovascular Events

Journal of the American College of Cardiology, 2005-05, Vol.45 (9), p.1505-1512

2005

Volltextzugriff (PDF)

Comparison of C-11 Methionine and C-11 Choline for PET Imaging of Brain Metastases: A Prospective Pilot Study

Clinical nuclear medicine, 2011-08, Vol.36 (8), p.639-642

2011

Volltextzugriff (PDF)

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

Blood, 2016-12, Vol.128 (22), p.1857-1857

2016

Volltextzugriff (PDF)

Increased metabolic activity in the thymus gland studied with (18)F-FDG PET: Age dependency and frequency after chemotherapy

The Journal of nuclear medicine (1978), 2001-04, Vol.42 (4), p.591

2001

Volltextzugriff (PDF)

Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours

Nuclear medicine communications, 2006-01, Vol.27 (1), p.17-24

2006

Volltextzugriff (PDF)

Reproducibility of PET brain mapping of cancer patients

Psycho-oncology (Chichester, England), 2000-03, Vol.9 (2), p.157-163

2000

Volltextzugriff (PDF)

Optimal number of image slices for reliable measurement of left ventricular volumes and ejection fraction by three-dimensional transesophageal echocardiography

Journal of medical ultrasonics (2001), 2004-06, Vol.31 (2), p.59-65

2004

Volltextzugriff (PDF)

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)

Blood, 2014-12, Vol.124 (21), p.391-391

2014

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(74)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(38)
Science & Technology
(33)
Life Sciences & Biomedicine
(32)
Middle Aged
(25)
Male
(24)
Female
(22)
Adult
(18)
Aged
(16)
Biological And Medical Sciences
(15)
Radiology, Nuclear Medicine & Medical Imaging
(15)
Medical Sciences
(13)
Fluorodeoxyglucose F18
(10)
Radiopharmaceuticals
(10)
Sensitivity And Specificity
(10)
Positron Emission Tomography
(8)
Reproducibility Of Results
(8)
Tomography, Emission-Computed
(8)
Positron-Emission Tomography - Methods
(7)
Adolescent
(6)
Diagnosis, Differential
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comment on Sundin et al.: ENETS Consensus Guidelines

Positron Emission Tomography/Computed Tomography and Whole-Body Magnetic Resonance Imaging in Staging of Advanced Nonsmall Cell Lung Cancer—Initial Results

Long-term benefit of intracardiac delivery of autologous granulocyte–colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct

Factors Influencing [F‐18] 2‐Fluoro‐2‐Deoxy‐d‐Glucose (F‐18 FDG) Uptake in Melanoma Cells: The Role of Proliferation Rate, Viability, Glucose Transporter Expression and Hexokinase Activity

FDG-PET imaging for the staging and follow-up of small cell lung cancer

Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome

Factors Influencing [F‐18] 2‐Fluoro‐2‐Deoxy‐d‐Glucose (F‐18 FDG) Accumulation in Melanoma Cells: Is FDG a Substrate of Multidrug Resistance (MDR)?

First clinical evidence that imaging with somatostatin receptor antagonists is feasible

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method

Residual thymic tissue and lymph node involvement by acute myeloid leukaemia presenting as mediastinal, strongly 18 FDG-PET-positive masses

Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV max Method

Residual thymic tissue and lymph node involvement by acute myeloid leukaemia presenting as mediastinal, strongly 18FDG‐PET‐positive masses

Thymic Carcinoma with Overexpression of Mutated KIT and the Response to Imatinib

Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene

Fluorine-18 DOPA PET Imaging of Paraganglioma Syndrome

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Positron Emission Tomography-Measured Abnormal Responses of Myocardial Blood Flow to Sympathetic Stimulation Are Associated With the Risk of Developing Cardiovascular Events

Comparison of C-11 Methionine and C-11 Choline for PET Imaging of Brain Metastases: A Prospective Pilot Study

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

Increased metabolic activity in the thymus gland studied with (18)F-FDG PET: Age dependency and frequency after chemotherapy

Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours

Reproducibility of PET brain mapping of cancer patients

Optimal number of image slices for reliable measurement of left ventricular volumes and ejection fraction by three-dimensional transesophageal echocardiography

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)

Suchergebnisse filtern